Leon-Diaz F, Chamontin C, Laine S, Socol M, Bertrand E, Mougel M
J Cell Biol. 2025; 224(4).
PMID: 39868815
PMC: 11775842.
DOI: 10.1083/jcb.202405075.
Samundeshwari E, Kattaru S, Kodavala S, Chandrasekhar C, Sarma P
Front Cell Dev Biol. 2025; 12:1450543.
PMID: 39744010
PMC: 11688275.
DOI: 10.3389/fcell.2024.1450543.
Fischell J, Fishman P
Front Neurosci. 2021; 15:747726.
PMID: 34630029
PMC: 8497810.
DOI: 10.3389/fnins.2021.747726.
Garcia-Perez L, van Eggermond M, van Roon L, Vloemans S, Cordes M, Schambach A
Mol Ther Methods Clin Dev. 2020; 17:666-682.
PMID: 32322605
PMC: 7163047.
DOI: 10.1016/j.omtm.2020.03.016.
Veitia R
J Mol Cell Biol. 2019; 11(8):719-722.
PMID: 30806666
PMC: 6788724.
DOI: 10.1093/jmcb/mjz014.
ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D, Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Yilmaz T
J Clin Immunol. 2018; 38(4):484-493.
PMID: 29744787
DOI: 10.1007/s10875-018-0496-9.
Gene Therapy for Metabolic Diseases.
Chandler R, Venditti C
Transl Sci Rare Dis. 2016; 1(1):73-89.
PMID: 27853673
PMC: 5108627.
DOI: 10.3233/TRD-160007.
Advances in gene therapy for muscular dystrophies.
Abdul-Razak H, Malerba A, Dickson G
F1000Res. 2016; 5.
PMID: 27594988
PMC: 4991540.
DOI: 10.12688/f1000research.8735.1.
Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.
Nagree M, Lopez-Vasquez L, Medin J
World J Stem Cells. 2016; 7(11):1233-50.
PMID: 26730268
PMC: 4691692.
DOI: 10.4252/wjsc.v7.i11.1233.
[Heterogeneity of hematopoietic stem cell].
Chen C, Hao S, Cheng T
Zhonghua Xue Ye Xue Za Zhi. 2015; 36(10):878-82.
PMID: 26477773
PMC: 7364952.
DOI: 10.3760/cma.j.issn.0253-2727.2015.10.018.
Assessing risk/benefit for trials using preclinical evidence: a proposal.
Kimmelman J, Henderson V
J Med Ethics. 2015; 42(1):50-3.
PMID: 26463620
PMC: 4854630.
DOI: 10.1136/medethics-2015-102882.
Insights into the nuclear export of murine leukemia virus intron-containing RNA.
Pessel-Vivares L, Houzet L, Laine S, Mougel M
RNA Biol. 2015; 12(9):942-9.
PMID: 26158194
PMC: 4615294.
DOI: 10.1080/15476286.2015.1065375.
Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review).
Wan C, Li F, Li H
Mol Med Rep. 2015; 12(4):4803-14.
PMID: 26151686
PMC: 4581786.
DOI: 10.3892/mmr.2015.4054.
Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome.
Liu Q, Wang X, Ma J, He X, Wang X, Zhou J
Viruses. 2015; 7(6):3241-60.
PMID: 26102582
PMC: 4488736.
DOI: 10.3390/v7062769.
Adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases.
Kuroda M, Bujo H, Aso M, Saito Y
J Diabetes Investig. 2014; 2(5):333-40.
PMID: 24843509
PMC: 4019298.
DOI: 10.1111/j.2040-1124.2011.00133.x.
No evidence of clonal dominance after transplant of HOXB4-expanded cord blood cells in a nonhuman primate model.
Watts K, Beard B, Wood B, Trobridge G, Humphries R, Adams A
Exp Hematol. 2014; 42(7):497-504.
PMID: 24704161
PMC: 4287401.
DOI: 10.1016/j.exphem.2014.03.007.
MLV requires Tap/NXF1-dependent pathway to export its unspliced RNA to the cytoplasm and to express both spliced and unspliced RNAs.
Pessel-Vivares L, Ferrer M, Laine S, Mougel M
Retrovirology. 2014; 11:21.
PMID: 24597485
PMC: 4015919.
DOI: 10.1186/1742-4690-11-21.
The era of genomic medicine.
Davies K
Clin Med (Lond). 2013; 13(6):594-601.
PMID: 24298109
PMC: 5873664.
DOI: 10.7861/clinmedicine.13-6-594.
Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
Horino S, Uchiyama T, So T, Nagashima H, Sun S, Sato M
PLoS One. 2013; 8(8):e71594.
PMID: 23990961
PMC: 3749225.
DOI: 10.1371/journal.pone.0071594.
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.
Fairclough R, Wood M, Davies K
Nat Rev Genet. 2013; 14(6):373-8.
PMID: 23609411
DOI: 10.1038/nrg3460.